close

New solution for stem cell manufacturing

New solution for stem cell manufacturing Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost. [caption id="attachment_10614" align="aligncenter" width="700"] Modular 3D printed microfluidic system©Majid Warkiani et al. Bioresources…..

Novartis expands Zolgensma® manufacturing capacity with approval of multi-product North Carolina facility

Novartis expands Zolgensma® manufacturing capacity with approval of multi-product North Carolina facility   The FDA has granted commercial licensure approval for Novartis' Durham, N.C. site, a multi-product gene therapy manufacturing facility. This approval allows the state-of-the-art, 170,000 square-foot facility to make, test and release commercial Zolgensma®, as well as produce…..

Touchlight and Versameb announce GMP manufacturing supply agreement to support the development of novel mRNA-based therapeutics

Touchlight and Versameb announce GMP manufacturing supply agreement to support the development of novel mRNA-based therapeutics Touchlight, a UK biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution, has concluded a development and manufacturing pipeline agreement with Versameb, a Swiss pre-clinical stage company focused on discovering and…..

MaaT Pharma and SkyePharma to establish the first microbiome-based therapeutics manufacturing facility in France

MaaT Pharma and SkyePharma to establish the first microbiome-based therapeutics manufacturing facility in France MaaT Pharma and Skyepharma have entered a partnership agreement to build SkyeHub Bioproduction, a new manufacturing facility near Lyon. This new plant will be France’s largest specialized cGMP manufacturing facility for ecosystem microbiome-based therapeutics. SkyeHub Bioproduction…..

VIVEbiotech expands facilities to increase innovation and manufacturing capabilities of specialist lentiviral vectors

VIVEbiotech expands facilities to increase innovation and manufacturing capabilities of specialist lentiviral vectors VIVEbiotech, a Spanish CDMO focused on the manufacture of lentiviral vectors from R&D early stages to GMP, is expanding its manufacturing capabilities with new facilities. This expansion will enable increased production capacity and the further optimization of…..

Ultragenyx will build a new gene therapy manufacturing facility in Bedford (MA)

Ultragenyx will build a new gene therapy manufacturing facility in Bedford Ultragenyx Pharmaceutical, a US biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases, plans to build a new large-scale gene therapy manufacturing facility in Bedford, Massachusetts.…..